The activity of the rare diseases unit is aimed at the development and introduction of advanced technologies for the treatment of life-threatening orphan diseases. Our activities focus on genetic and severe, disabling diseases such as lysosomal storage diseases.
Guided by our commitment to patients, we maintain and develop partnerships with experts in research and professional circles.
Such cooperation is an important part of our work, since we intend to expand the boundaries of the possibilities of medicine and technology, creating the best, previously inaccessible, drugs.
Each area of our division is focused on serving the needs of patients, based on an individual approach and the provision of highly specialized products and services..